- Forums
- ASX - By Stock
- ALL
- ALL - 'ALL in ' Why ALL is a defensive against
ALL - 'ALL in ' Why ALL is a defensive against, page-53
-
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ALL (ASX) to my watchlist
|
|||||
Last
$52.34 |
Change
-1.325(2.47%) |
Mkt cap ! $33.27B |
Open | High | Low | Value | Volume |
$53.49 | $53.50 | $52.30 | $25.03M | 474.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 28 | $52.33 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$52.34 | 14 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 54 | 52.330 |
1 | 32 | 52.320 |
4 | 140 | 52.310 |
5 | 1153 | 52.300 |
4 | 197 | 52.290 |
Price($) | Vol. | No. |
---|---|---|
52.340 | 505 | 8 |
52.350 | 208 | 4 |
52.360 | 316 | 7 |
52.370 | 295 | 12 |
52.380 | 225 | 7 |
Last trade - 11.54am 16/07/2024 (20 minute delay) ? |
Featured News
ALL (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online